Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial.
暂无分享，去创建一个
Deepak L. Bhatt | Lawrence A Leiter | R. Diaz | M. Sabatine | S. Murphy | D. McGuire | K. Park | S. Wiviott | I. Raz | John P H Wilding | J. Kuder | A. Cahn | J. Špinar | Ofri Mosenzon | A. Goudev | K. Oyama | I. Gause-Nilsson